Camber Capital Management as of Sept. 30, 2017
Portfolio Holdings for Camber Capital Management
Camber Capital Management holds 23 positions in its portfolio as reported in the September 2017 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf (SPY) | 23.9 | $377M | 1.5M | 251.23 | |
| Nektar Therapeutics (NKTR) | 7.9 | $125M | 5.2M | 24.00 | |
| Tenet Healthcare Corporation (THC) | 6.0 | $95M | 5.8M | 16.43 | |
| Mylan Nv | 5.4 | $85M | 2.7M | 31.37 | |
| Perrigo Company (PRGO) | 5.2 | $83M | 975k | 84.65 | |
| Genomic Health | 5.0 | $79M | 2.5M | 32.09 | |
| Myriad Genetics (MYGN) | 4.6 | $72M | 2.0M | 36.18 | |
| Envision Healthcare | 4.3 | $67M | 1.5M | 44.95 | |
| Orthofix International Nv Com Stk | 4.1 | $65M | 1.4M | 47.25 | |
| Hca Holdings (HCA) | 4.0 | $64M | 800k | 79.59 | |
| Sarepta Therapeutics (SRPT) | 4.0 | $64M | 1.4M | 45.36 | |
| Brookdale Senior Living (BKD) | 3.6 | $57M | 5.4M | 10.60 | |
| Bioverativ Inc Com equity | 3.6 | $57M | 1.0M | 57.07 | |
| Tesaro | 3.3 | $52M | 400k | 129.10 | |
| AMAG Pharmaceuticals | 3.1 | $49M | 2.7M | 18.45 | |
| Radius Health | 2.8 | $44M | 1.2M | 38.55 | |
| Gilead Sciences (GILD) | 2.6 | $41M | 500k | 81.02 | |
| Endologix | 2.3 | $36M | 8.0M | 4.46 | |
| Invitae (NVTAQ) | 1.4 | $23M | 2.4M | 9.37 | |
| BioScrip | 1.1 | $17M | 6.3M | 2.75 | |
| Clovis Oncology | 1.1 | $17M | 200k | 82.40 | |
| Atara Biotherapeutics | 0.6 | $8.9M | 536k | 16.55 | |
| Biolase Technology | 0.0 | $0 | 7.2M | 0.00 |
